Concepedia

Laura Meléndez‐Alafort

LM

40

Publications

1.2K

Citations

20

H-Index

1997

Active since

Affiliations

Istituto Oncologico Veneto(Current)

Instituto Nacional de Investigaciones Nucleares

University of Padua

Istituti di Ricovero e Cura a Carattere Scientifico

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Laura Meléndez‐Alafort is an author at Istituto Oncologico Veneto specializing in medicine, radiation oncology, and engineering.

ORCID

Top concepts

Publications per year

1997–2024

40

Publications

40

99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.

Clemens Decristoforo, Laura Meléndez‐Alafort, Jane Sosabowski et al. · PubMed · 2000 · 162 citations

A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent <i>In vivo</i> Therapeutic Activity

Alessandra Banzato, Sara Bobisse, Maria Rondina et al. · Clinical Cancer Research · 2008 · 89 citations · Full text

Biokinetics of 99mTc-UBI 29-41 in humans

Laura Meléndez‐Alafort, J. Rodríguez-Cortés, Guillermina Ferro‐Flores et al. · Nuclear Medicine and Biology · 2004 · 83 citations

, , +1

In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria

Guillermina Ferro‐Flores, Consuelo Arteaga de Murphy, Martha Pedraza-López et al. · Nuclear Medicine and Biology · 2003 · 81 citations

, , +5

177Lu-Bombesin-PLGA (paclitaxel): A targeted controlled-release nanomedicine for bimodal therapy of breast cancer

Brenda Gibbens-Bandala, Enrique Morales-Ávila, Guillermina Ferro‐Flores et al. · Materials Science and Engineering C · 2019 · 61 citations · Full text

, , +13

Rows per page

1–5 of 40